Molecular Formula | C32H30F5N3O5 |
Molar Mass | 631.595 |
Density | 1.350 |
Boling Point | 728.6±70.0 °C(Predicted) |
pKa | 4.40±0.10(Predicted) |
Storage Condition | 2-8℃ |
Physical and Chemical Properties | Physical and chemical properties: elagolix is an oral GnRH antagonist jointly developed by Abbvie and partner Neurocrine Biosciences. It inhibits the pituitary gonadotropin-releasing hormone receptor and ultimately reduces the level of gonadal hormones in blood circulation. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.583 ml | 7.916 ml | 15.833 ml |
5 mM | 0.317 ml | 1.583 ml | 3.167 ml |
10 mM | 0.158 ml | 0.792 ml | 1.583 ml |
5 mM | 0.032 ml | 0.158 ml | 0.317 ml |